Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pranoti V Sahasrabhojane"'
Autor:
Georgios Angelidakis, Roy F. Chemaly, Pranoti V. Sahasrabhojane, Oscar Morado-Aramburo, Ying Jiang, Micah M. Bhatti, Elizabeth Shpall, Chitra Hosing, Preetesh Jain, Kris Michael Mahadeo, Fareed Khawaja, Peter Elhajj, Jennifer A. Wargo, Robert R. Jenq, Nadim J. Ajami, Partow Kebriaei, Ella J. Ariza-Heredia
Publikováno v:
Vaccines, Vol 12, Iss 9, p 1070 (2024)
Patients undergoing immune effector cell therapy (IECT) are at high risk for infections. We assessed seropositivity against pneumococcus, tetanus, and diphtheria in patients before and after IECT and the patients’ response to vaccination. We enroll
Externí odkaz:
https://doaj.org/article/b2bd91b9270a46a1a6315748347f8e51
Autor:
Samantha Franklin, Samuel L. Aitken, Yushi Shi, Pranoti V. Sahasrabhojane, Sarah Robinson, Christine B. Peterson, Naval Daver, Nadim A. Ajami, Dimitrios P. Kontoyiannis, Samuel A. Shelburne, Jessica Galloway-Peña
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Failure to maintain segregation of oral and gut microbial communities has been linked to several diseases. We sought to characterize oral-fecal microbiome community coalescence, ectopic extension of oral bacteria, clinical variables contributing to t
Externí odkaz:
https://doaj.org/article/fa6a0fdef875457a8afce22c6e36d929
Autor:
Gohel Marc, Hatim Amiji, Benjamin Strope, Pranoti V Sahasrabhojane, David E Greenberg, William Shropshire, Samuel A Shelburne
Publikováno v:
Open Forum Infectious Diseases. 9
Background Whole-genome sequencing has gained interest for assessing antimicrobial resistance (AMR). However, multiple studies have shown a poor correlation between the β-lactam/β-lactamase inhibitor (BL/BLI) phenotype and β-lactamase gene presenc
Autor:
Stephanie McMahon, B S Microbiology, Jessica Galloway-Peña, Pranoti V Sahasrabhojane, Samuel A Shelburne
Publikováno v:
Open Forum Infectious Diseases. 9
Background Blood stream infections (BSI) are a common cause of morbidity and mortality in immunocompromised patients. It was previously reported that intestinal domination (defined as occupation of ≥ 30% of the microbiota by a single bacterial taxo
Autor:
German A Contreras, Jose M Munita, Shelby Simar, Courtney Luterbach, An Q Dinh, Kirsten Rydell, Pranoti V Sahasrabhojane, Rafael Rios, Lorena Diaz, Katherine Reyes, Marcus Zervos, Helina M Misikir, Gabriela Sanchez-Petitto, Catherine Liu, Yohei Doi, Lilian M Abbo, Luis Shimose, Harald Seifert, Carlota Gudiol, Fernanda Barberis, Claudia Pedroza, Samuel L Aitken, Samuel A Shelburne, David van Duin, Truc T Tran, Blake M Hanson, Cesar A Arias
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Background Vancomycin-resistant enterococci (VRE) are major therapeutic challenges. Prospective contemporary data characterizing the clinical and molecular epidemiology of VRE bloodstream infections (BSIs) are lacking. Methods The Vancomycin-Resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c96449906142a4d4eb652b9e21009b4
http://hdl.handle.net/2445/183781
http://hdl.handle.net/2445/183781
Autor:
Shelby Simar, Blake Hanson, German Contreras, Katherine Reyes, Pranoti V Sahasrabhojane, Helina Misikir, Catherine Liu, Yohei Doi, Fernanda Barberis, Lilian Abbo, An Q Dinh, Maria Spencer, Marcus Zervos, Samuel L Aitken, David van Duin, Samuel A Shelburne, Truc T Tran, Jose M Munita, Cesar A Arias, Maria de los Angeles Spencer
Publikováno v:
Open Forum Infectious Diseases
Background Vancomycin-resistant enterococci (VRE) are a major cause of nosocomial bloodstream infections. Enterococci exhibit remarkable genomic plasticity and can recombine through the acquisition of genetic material via mobile genetic elements (MGE
Autor:
Samuel L Aitken, Bradley T Endres, Ayesha Khan, William C Shropshire, Jovan Borjan, Micah M Bhatti, Pranoti V Sahasrabhojane, Yohei Doi, Ryan K Shields, Samuel A Shelburne
Publikováno v:
Open Forum Infectious Diseases
Background Ceftazidime–avibactam (CZA) is a novel β-lactam / β-lactamase inhibitor with in vitro activity against multidrug-resistant Gram-negatives, including those harboring CMY-2 enzymes. Treatment-emergent resistance to CZA has been described
Autor:
Bradley T Endres, Michael J Buege, Kayleigh Marx, Pranoti V Sahasrabhojane, Jessica Galloway-Peña, Kevin W Garey, Jiwoong Kim, David E Greenberg, Xiaowei Zhan, Samuel A Shelburne, Samuel L Aitken
Publikováno v:
Open Forum Infectious Diseases
Background Fluoroquinolones (FQs) are routinely used as antimicrobial prophylaxis in leukemia patients receiving chemotherapy to prevent Pseudomonas aeruginosa infections. Patients who are intolerant to FQs may receive cefpodoxime (CPD) or other agen